AtriCure, Inc.
ATRC
Jodie situation report
AtriCure, Inc.'s move is being confirmed by its market group.
ATRC accounts for 4.1% of the group's measured movement across 7.1 effective names. raw member direction is mixed; 0 of 11 SPY-adjusted paths align to the mixed. Capital-flow agreement is 28%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
ATRC was the first measured mover. ATRC crossed its material path threshold at 10:30 ET. MRK, PFE, PBH followed.
6 of 11 members in Biopharmaceuticals and Care are active. 0 of 2 disclosed connections are confirming.
- At least 8 of 11 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as INVA begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.
Who this business touches
The relationships behind ATRC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
JPMJP Morgan Chase & Co.lenderMay 6, 2026 ▾
“The Company's Credit Agreement with JPMorgan Chase Bank, N.A.”
MDTMedtronic plc.competitorFeb 19, 2026 ▾
“Our primary competitor in the cardiac surgery market is Medtronic, plc, who provides surgical ablation products and LAAM devices used by physicians for the treatment of Afib and related conditions.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ATRC is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.